Literature DB >> 9882308

Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.

P G Stevenson1, P C Doherty.   

Abstract

The murine gammaherpesvirus MHV-68 multiplies in the respiratory epithelium after intranasal inoculation, then spreads to infect B cells in lymphoid germinal centers. Exposing B cells to MHV-68 in vitro caused an increase in cell size, up-regulation of the CD69 activation marker, and immunoglobulin M (IgM) production. The infectious process in vivo was also associated with increased CD69 expression on B cells in the draining lymph nodes and spleen, together with a rise in total serum Ig. However, whereas the in vitro effect on B cells was entirely T-cell independent, evidence of in vivo B-cell activation was minimal in CD4(+) T-cell-deficient (I-Ab-/-) or CD4(+) T-cell-depleted mice. Furthermore, the Ig present at high levels in serum was predominantly of the IgG class. Surprisingly, the titer of influenza virus-specific serum IgG in previously immunized mice fell following MHV-68 infection, suggesting that there was relatively little activation of memory B cells. Thus, CD4(+) T cells seemed both to amplify a direct viral activation of B cells in lymphoid tissue and to promote new Ig class switching despite a lack of obvious cognate antigen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882308      PMCID: PMC103927     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.

Authors:  A Rosén; P Gergely; M Jondal; G Klein; S Britton
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

Review 3.  Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis.

Authors:  C J Chapman; D Wright; F K Stevenson
Journal:  Leuk Lymphoma       Date:  1998-07

Review 4.  Consequences of viral infections for lymphocyte compartmentalization and homeostasis.

Authors:  P C Doherty; A M Hamilton-Easton; D J Topham; J Riberdy; J W Brooks; R D Cardin
Journal:  Semin Immunol       Date:  1997-12       Impact factor: 11.130

5.  A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.

Authors:  E Hatzivassiliou; W E Miller; N Raab-Traub; E Kieff; G Mosialos
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

6.  Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency.

Authors:  R J Bowden; J P Simas; A J Davis; S Efstathiou
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

7.  Characteristics of a murine gammaherpesvirus infection immunocompromised mice.

Authors:  A B Kulkarni; K L Holmes; T N Fredrickson; J W Hartley; H C Morse
Journal:  In Vivo       Date:  1997 Jul-Aug       Impact factor: 2.155

8.  Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies.

Authors:  E Klemola; R Von Essen; G Henle; W Henle
Journal:  J Infect Dis       Date:  1970-06       Impact factor: 5.226

9.  Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice.

Authors:  S R Sarawar; J W Brooks; R D Cardin; M Mehrpooya; P C Doherty
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

10.  B cell activation by cytomegalovirus.

Authors:  L M Hutt-Fletcher; N Balachandran; M H Elkins
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  55 in total

1.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.

Authors:  Rebecca L Sparks-Thissen; Douglas C Braaten; Scott Kreher; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation.

Authors:  Emilio Flaño; Basak Kayhan; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection.

Authors:  Rebecca A Elsner; David N Ernst; Nicole Baumgarth
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 5.  The isolator piglet: a model for studying the development of adaptive immunity.

Authors:  J E Butler; Marek Sinkora
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo.

Authors:  Haiyan Li; Kazufumi Ikuta; John W Sixbey; Scott A Tibbetts
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.

Authors:  Andrew Getahun; Mia J Smith; Igor Kogut; Linda F van Dyk; John C Cambier
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

8.  Glycoprotein L sets the neutralization profile of murid herpesvirus 4.

Authors:  Laurent Gillet; Marta Alenquer; Daniel L Glauser; Susanna Colaco; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

9.  Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice.

Authors:  Laurent Gillet; Michael B Gill; Susanna Colaco; Christopher M Smith; Philip G Stevenson
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

10.  An in vitro system for studying murid herpesvirus-4 latency and reactivation.

Authors:  Janet S May; Neil J Bennett; Philip G Stevenson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.